01-01-1970 12:00 AM | Source: Reuters
Indias Bharat Biotech to supply Covaxin to states, hospitals at Rs 600-1,200 per dose
India's Bharat Biotech said on Saturday that it will supply Covaxin directly to state governments at 600 rupees per dose, while it will supply the vaccine directly to private hospitals at 1,200 rupees per dose.
In a tweet, the company said it will develop, manufacture and supply Covaxin to India's central government at 150 rupees per dose. https://bit.ly/2S1W3zC
The company added that more than 50% of its vaccine capacities have been reserved for supply to the central government.
(Reporting by Juby Babu in Bengaluru; Editing by Marguerita Choy)
Latest News
Evening Roundup : A Daily Report on Bullion Energy &...
ITI AMC announces activation of new OPA
India's Blue Star posts jump in Q4 adjusted profit o...
Gautam Adani meets new British envoy to India, wishe...
FIIs stood as net buyers in equities as per May 02 d...
NPCI partners Bank of Namibia to develop UPI-like pa...
Report on power sector equity raises to power up to ...
Motilal Oswal Flexicap Fund Celebrates a Decade of H...
Buy Zinc above 258.50 SL below 256.50tct 261/262 - A...
Blue Star`s FY24 Total Income rises 21.4% to Rs 9685...
Tag News
Bharat Biotech evinces interest to invest in Karnataka
Key Stock News: JSW Group , Aditya Birla Fashion and Retail Limited , Bharat Biotech , Adani group - ARETE Securities
Key News - Vedanta Ltd, Mindtree Ltd, Reliance Industries Limited Ltd, Bharat Biotech, Braithwaite & Co Ltd By ARETE Securities
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster